Midgard Science

Labs / CDMO: development & manufacturing

AltPep

Seattle, WA, United States · altpep.com

GMP

AltPep develops disease-modifying treatments and detection tools for amyloid diseases. Its lead programs focus on Alzheimer’s and Parkinson’s disease, with early detection and treatment programs based in Seattle, Washington.

They take quote requests by email.

What they offer

  • Therapeutics development

    Develops α-sheet-targeting peptide therapeutics intended to detect and neutralize toxic soluble oligomers in amyloid diseases.

  • Diagnostics development

    Develops highly sensitive blood tests intended to aid in the detection of amyloid diseases.

What they work on

Modalities
Small molecule, Antibody, Peptide, Oligonucleotide
Assays and studies
blood tests
Therapeutic areas
amyloid diseases, Alzheimer’s disease, Parkinson’s disease
Sites
Seattle, USA
Address
1150 Eastlake Avenue E., Suite 800 Seattle, WA 98109
Founded
2020

Public records

CLIA
50D2225744
CMS CLIA laboratory
50D2225744 · SEATTLE source

Similar labs. Aurigene Pharmaceutical Services, Sai Life, ARSI Canada Inc, Esco Aster

Found in a contract services directory. Listing built from altpep.com. Work here? Claim this listing.

AltPep · Midgard Science